- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT07655063
The Green Room: Virtual Nature for Mental Well-being in the Acute Psychiatry Ward (GREEN ROOM)
The Green Room: A Mixed-Methods Randomized Controlled Trial Evaluating Virtual Reality-Based Nature Exposure in an Acute Psychiatry Ward
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
THE GREEN ROOM is a sequential, explanatory mixed-methods study comprising two phases. Phase 1 is a qualitative study (n=40; patients and healthcare professionals) using the Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework to identify barriers and facilitators to VR implementation in an acute psychiatric ward, and to co-create the final VR intervention content with patients and staff. Phase 2 is the randomised controlled trial described in this record.
Phase 2 participants are randomised 1:1 to receive VR-based nature exposure sessions (Nature Treks VR, Meta Quest 3) in addition to treatment as usual, or treatment as usual alone. Randomisation is stratified by legal admission status (voluntary vs. involuntary) using two separate pre-generated sequential allocation lists (n=60 per stratum). Allocation concealment is maintained through sequential, pre-fixed assignment managed by the research assistant; the Principal Investigator remains blinded to individual allocations during data collection, and the statistical analyst remains blinded until the analysis plan is finalised and locked.
Intervention-group participants are offered VR sessions of 10\u201315 minutes approximately every other day throughout hospitalisation, on a strictly voluntary basis. Participants may freely choose and switch between all nature environments available within the Nature Treks VR application. During the first VR session, a consecutive sub-sample of intervention participants (estimated n\u224850) additionally undergo physiological monitoring (heart rate and heart rate variability) using a consumer-grade wearable device (Fitbit).
The primary analysis will use a mixed-design ANOVA (or ANCOVA with baseline score as covariate) to evaluate change in PSS-10 from admission to discharge, following an intention-to-treat approach. Missing data will be handled under a Missing-At-Random assumption within the mixed-effects model framework, with complete-case analysis as a sensitivity check. Two exploratory subgroup analyses are pre-specified: by legal admission status and by primary diagnostic category.
Typ studie
Zápis (Odhadovaný)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Barcelona
-
Barcelona, Barcelona, Španělsko
- Hospital Clinic De Barcelona
-
Kontakt:
- Pablo Barrio
- Telefonní číslo: 4210 +34932275400
- E-mail: pbarrio@clinic.cat
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Popis
Inclusion Criteria:
Adults aged 18 to 65 years. Admitted to the Acute Psychiatry Ward (regardless of voluntary or involuntary legal status).
Sufficient cognitive and clinical stability to provide informed consent and engage with the VR equipment, as determined by the clinical team.
Ability to communicate effectively in Spanish.
Exclusion Criteria:
History of photosensitive epilepsy or severe seizure disorders. Presence of active facial injuries, infections, or skin conditions that prevent the hygienic use of the VR headset.
Pre-existing severe vertigo, balance disorders, or high susceptibility to motion sickness.
Acute clinical state involving high risk of agitation or behavioral dysregulation that could compromise participant or equipment safety.
Severe visual or hearing impairments that cannot be corrected and would hinder the VR experience.
Patients who have previously participated in the study during a prior admission are not eligible for re-enrolment.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Podpůrná péče
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Singl
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: VR + Treatment as Usual
Participants receive voluntary VR nature sessions (10-15 minutes, every other day) using Meta Quest 3, in addition to standar psychiatric care.
|
Voluntary immersive nature sessions using Nature Treks VR softwere on Meta Quest 3 head-mounted displays.
Sessions last 10-15 minutes and are offered every other day throughout hospitalization.
Participants freely choose among all available nature environments within the application.
|
|
Aktivní komparátor: Treatment as Usual (TAU)
Participantrs receive standard pharmacological and psychotherapeutic care provided by the acute psychiatry ward, without VR sessions.
|
Standard pharmacological and psychotherapeutic interventions provided by the acute psychiatry ward.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Change in Perceived Stress Scale-10 (PSS-10) score
Časové okno: From admission (baseline) to discharge (average 2-3 weeks)
|
Change in PSS-10 total score from baseline assessment (T0, al clinical stabilization) to discharge assessment (T2).
The Perceived Stress Scale-10 (PSS-10) is a 10-item self-report questionnaire measuring the degree to which situations in one's life are appraised as stressful.
Scores range from 0 to 40, with higher scores indicating greater perceived stress.
|
From admission (baseline) to discharge (average 2-3 weeks)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
World Health Organization-Five Well-Being Index (WHO-5) score
Časové okno: Through study completion, an average of 2 weeks
|
The WHO-5 is a 5-item self-report measure of psychological well-being.
Raw scores range from 0 to 25, with higher scores indicating better well-being.
|
Through study completion, an average of 2 weeks
|
|
Views On Inpatient Care (VOICE) score
Časové okno: Through study completion, an average of 2 weeks
|
The VOICE is a patient-reported outcome measure assessing satisfaction with inpatient psychiatric care.
Scores range from 0 to 42, with higher scores indicating greater satisfaction.
|
Through study completion, an average of 2 weeks
|
|
Client's Assessment of Treatment (CAT) score
Časové okno: Through study completion, an average of 2 weeks
|
The CAT is an 8-item self-report measure of satisfaction with inpatient psychiatric treatment.
Scores range from 8 to 40, with higher scores indicating greater satisfaction.
|
Through study completion, an average of 2 weeks
|
|
Length of hospital stay
Časové okno: From admission to discharge, an average of 2 weeks
|
Total number of days from admission to discharge, extracted from medical records.
|
From admission to discharge, an average of 2 weeks
|
|
Rate of discharge against medical advice (DAMA)
Časové okno: Throughout hospitalization, an average 2 weeks.
|
Proportion of participants who self-discharge against medical advice during the study period.
|
Throughout hospitalization, an average 2 weeks.
|
|
State-Trait Anxiety Inventory - State subscale (STAI-S) score
Časové okno: Day 1
|
The STAI-S is a 20-item self-report measure of state anxiety.
Scores range from 20 to 80, with higher scores indicating greater anxiety.
|
Day 1
|
|
Positive and Negative Affect Schedule (PANAS) score
Časové okno: Day 1
|
The PANAS consists of two 10-item subscales measuring positive and negative affect.
Each subscale ranges from 10 to 50.
For the positive affect subscale, higher scores indicate more positive affect (better outcome); for the negative affect subscale, higher scores indicate more negative affect (worse outcome).
|
Day 1
|
|
System Usability Scale (SUS) score
Časové okno: Day 1
|
The SUS is a 10-item questionnaire assessing perceived usability of a system.
Scores range from 0 to 100, with higher scores indicating better usability.
|
Day 1
|
|
Simulator Sickness Questionnaire (SSQ) total severity score
Časové okno: Day 1
|
The SSQ is a 16-item checklist assessing symptoms of nausea, oculomotor disturbance, and disorientation associated with virtual reality use.
The total severity score ranges from 0 to 235.93, with higher scores indicating greater simulator sickness symptoms (worse outcome).
|
Day 1
|
|
Percentage of offered VR sessions accepted
Časové okno: Throughout hospitalization (intervention group only) an average 2 weeks.
|
Percentage of offered VR sessions accepted by each participant in the intervention group, ranging from 0% to 100%, as a measure of intervention adherence and feasibility.
Higher percentages indicate better adherence.
|
Throughout hospitalization (intervention group only) an average 2 weeks.
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Pablo Barrio Gimenez, Hospital Clinic of Barcelona
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Klíčová slova
Další relevantní podmínky MeSH
Další identifikační čísla studie
- HCB/2025/0704 (Identifikátor registru: CEIm- Hospital Clinic de Barcelona)
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na Duševní poruchy
-
Centre Hospitalier de GonesseZatím nenabírámeKognitivní dysfunkce | Alzheimerova nemoc | Pečovatelé | Neuropsychologické testy | Mini-Mental State zkouškaFrancie